VRDN — Viridian Therapeutics Inc. price, chart and key statistics

Price data

Price

$19.03

YTD price return

-38.85%

YTD total return

-38.85%

Next earnings

Nov 4, 2026

Market cap

2.2B2016-12 3.6M2026-10 2.2B+59721.1% over the window

Enterprise value

1.2B

Shares outstanding

113.3M2016-06 48K2026-06 113.3M+236135.1% over the window

52W low

$13.18

52W high

$34.29

From 52W high

-44.50%

From 52W low

+44.39%

52W range

28%

Volume

Rel volume

1.24×

30D volume

2M

30D $ vol

40M

Fundamentals

Sales (ttm)

71.1M2016-12 3.5M2026-06 71.1M+1945.6% over the window

Sales/share

$0.632016-12 $2.442026-06 $0.63-74.3% over the window

EPS (ttm)

-$3.422020-06 -$10.122025-06 -$4.22-58.4% over the window

FCF (ttm)

-335M2016-06 -12.5M2026-06 -335M+2578.8% over the window

FCF/share

-$2.962016-06 -$260.792026-06 -$2.96-98.9% over the window

Book value/share

$5.842016-06 $134.222026-06 $5.84-95.6% over the window

Net margin

-544.06%2016-12 -496.8%2026-06 -544.1%+9.5% over the window

ROE

-58.45%2016-06 -206.3%2026-06 -58.4%-71.7% over the window

ROA

-35.27%2016-06 -146.9%2026-06 -35.3%-76.0% over the window

Debt / equity

0.03×2017-03 0.092025-09 0.04-52.2% over the window

Current ratio

16.952016-06 3.072026-06 16.95+452.6% over the window

Growth (CAGR, ttm) · 10Y

Sales

+23307.57%2025-06-30 → 2026-06-30305K → 71.1M (+23220.3% total)+264.29%2023-06-30 → 2026-06-301.5M → 71.1M (+4738.6% total)+93.92%2021-06-30 → 2026-06-302.6M → 71.1M (+2640.9% total)+27.17%2015-12-31 → 2026-06-305.7M → 71.1M (+1146.5% total)

Shares

+38.76%2025-06-30 → 2026-06-3081.7M → 113.3M (+38.7% total)+37.40%2023-06-30 → 2026-06-3043.7M → 113.3M (+159.4% total)+67.45%2021-06-30 → 2026-06-308.6M → 113.3M (+1216.0% total)+117.46%2016-06-30 → 2026-06-3048K → 113.3M (+236135.1% total)

Per-share growth (CAGR, ttm) · 10Y

Sales/share

+16768.66%2025-06-30 → 2026-06-30$0.00 → $0.63 (+16709.6% total)+165.14%2023-06-30 → 2026-06-30$0.03 → $0.63 (+1765.1% total)+15.81%2021-06-30 → 2026-06-30$0.30 → $0.63 (+108.3% total)-39.37%2015-12-31 → 2026-06-30$119.88 → $0.63 (-99.5% total)

Book value/share

-7.37%2025-06-30 → 2026-06-30$6.31 → $5.84 (-7.4% total)-6.86%2023-06-30 → 2026-06-30$7.23 → $5.84 (-19.2% total)-12.65%2021-06-30 → 2026-06-30$11.49 → $5.84 (-49.1% total)-26.91%2016-06-30 → 2026-06-30$134.22 → $5.84 (-95.6% total)

Price

-17.31%2025-10-16 → 2026-10-16$23.01 → $19.03 (-17.3% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+17.00%2023-10-16 → 2026-10-16$11.88 → $19.03 (+60.2% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+2.20%2021-10-15 → 2026-10-16$17.07 → $19.03 (+11.5% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.-15.77%2016-10-14 → 2026-10-16$105.98 → $19.03 (-82.0% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.

Total return

-17.31%2025-10-16 → 2026-10-16$23.01 → $19.03 (-17.3% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+17.00%2023-10-16 → 2026-10-16$11.88 → $19.03 (+60.2% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+2.20%2021-10-15 → 2026-10-16$17.07 → $19.03 (+11.5% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.-15.77%2016-10-14 → 2026-10-16$105.98 → $19.03 (-82.0% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.

-5.6×2016-12 -0.252026-10 -5.57+2107.5% over the window

Fwd P/E

-6.8×

P/S (ttm)Market cap ÷ TTM revenue.

30.3×2016-12 0.632026-10 30.31+4699.0% over the window

P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.

3.3×2016-12 0.772026-10 3.26+323.4% over the window

EV/Sales (ttm)

17.0×

FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.

-15.54%2016-09 -361.5%2026-06 -16.1%-95.5% over the window

Buyback yield (realized, 1y)1 − shares_at(2026-06-30) ÷ shares_at(2025-06-30) = 1 − 113.3M ÷ 81.7M. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.

-38.76%

Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (-38.76%) + dividends paid over that year ($0) ÷ market_cap_at(2025-06-30) ($1.1B). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.

-38.76%

Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($-58.2M) ÷ today's market cap ($2.2B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.

-2.70%2016-09 0.0%2026-06 -2.8%

Shareholder yield (cash, ttm)(TTM buybacks net of issuance $-58.2M + TTM dividends $0) ÷ today's market cap ($2.2B). Same caveat as the cash buyback yield.

-2.70%2016-09 0.0%2026-06 -2.8%

Vs own 10Y history

P/S

32nd

P/B

76th